Mendus AB (publ) IMMU.ST Stock
9 SEK
{{ price }}
-4.051174%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
Sweden
Exchange
Stockholm
Market Cap
453.24M SEK
LOW - HIGH [24H]
9
-
9.37 SEK
VOLUME [24H]
13.57K SEK
{{ volume }}
P/E Ratio
0
Earnings per share
-2.2 SEK
Mendus AB (publ) Price Chart
Mendus AB (publ) IMMU.ST Financial and Trading Overview
| Mendus AB (publ) stock price | 9 SEK |
| Previous Close | 0.6 SEK |
| Open | 0.6 SEK |
| Bid | 0.59 SEK x 0 |
| Ask | 0.59 SEK x 0 |
| Day's Range | 0.58 - 0.6 SEK |
| 52 Week Range | 0.58 - 3.7 SEK |
| Volume | 188.2K SEK |
| Avg. Volume | 346.12K SEK |
| Market Cap | 124.41M SEK |
| Beta (5Y Monthly) | 1.157854 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.2 SEK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.85 SEK |
IMMU.ST Valuation Measures
| Enterprise Value | 193.39M SEK |
| Trailing P/E | N/A |
| Forward P/E | 4.2285714 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 90.8102 |
| Price/Book (mrq) | 0.2443252 |
| Enterprise Value/Revenue | 141.157 |
| Enterprise Value/EBITDA | -1.458 |
Trading Information
Mendus AB (publ) Stock Price History
| Beta (5Y Monthly) | 1.157854 |
| 52-Week Change | -73.18% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.7 SEK |
| 52 Week Low | 0.58 SEK |
| 50-Day Moving Average | 1.4 SEK |
| 200-Day Moving Average | 1.96 SEK |
IMMU.ST Share Statistics
| Avg. Volume (3 month) | 346.12K SEK |
| Avg. Daily Volume (10-Days) | 713.23K SEK |
| Shares Outstanding | 202.7M |
| Float | 103.01M |
| Short Ratio | N/A |
| % Held by Insiders | 55.98% |
| % Held by Institutions | 11.79% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -9904.45% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -12.70% |
| Return on Equity (ttm) | -25.31% |
Income Statement
| Revenue (ttm) | 1.37M SEK |
| Revenue Per Share (ttm) | 0.007 SEK |
| Quarterly Revenue Growth (yoy) | -85.00000000000000000000000000000000% |
| Gross Profit (ttm) | 3M SEK |
| EBITDA | -132673000 SEK |
| Net Income Avi to Common (ttm) | -141372000 SEK |
| Diluted EPS (ttm) | -0.64 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 37.5M SEK |
| Total Cash Per Share (mrq) | 0.19 SEK |
| Total Debt (mrq) | 109.67M SEK |
| Total Debt/Equity (mrq) | 22.48 SEK |
| Current Ratio (mrq) | 0.571 |
| Book Value Per Share (mrq) | 2.423 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -118997000 SEK |
| Levered Free Cash Flow (ttm) | -73354128 SEK |
Profile of Mendus AB (publ)
| Country | Sweden |
| State | N/A |
| City | Stockholm |
| Address | VAestra TrAedgArdsgatan 15 |
| ZIP | 111 53 |
| Phone | 46 87 32 84 00 |
| Website | https://www.mendus.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 33 |
Mendus AB (publ), a biopharmaceutical company, develops immunotherapies and relapse vaccines for the treatment of cancer. Its lead product is DCP-001, which is in Phase II ADVANCE-II clinical trial for the treatment of acute myeloid leukemia; and Phase I ALISON clinical trial for the treatment of ovarian cancers. The company's products also develops ilixadencel, which is in Phase II clinical trial for the treatment of kidney cancer; and Phase II clinical trial to treat gastrointestinal stromal tumors. It has a research collaboration with PCI Biotech Holding ASA for novel cancer vaccination treatment; and with Icahn School of Medicine at Mount Sinai. The company was formerly known as Immunicum AB (publ) and changed its name to Mendus AB (publ) in June 2022. Mendus AB (publ) was incorporated in 2002 and is headquartered in Stockholm, Sweden.
Q&A For Mendus AB (publ) Stock
What is a current IMMU.ST stock price?
Mendus AB (publ) IMMU.ST stock price today per share is 9 SEK.
How to purchase Mendus AB (publ) stock?
You can buy IMMU.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Mendus AB (publ)?
The stock symbol or ticker of Mendus AB (publ) is IMMU.ST.
Which industry does the Mendus AB (publ) company belong to?
The Mendus AB (publ) industry is Biotechnology.
How many shares does Mendus AB (publ) have in circulation?
The max supply of Mendus AB (publ) shares is 50.36M.
What is Mendus AB (publ) Price to Earnings Ratio (PE Ratio)?
Mendus AB (publ) PE Ratio is now.
What was Mendus AB (publ) earnings per share over the trailing 12 months (TTM)?
Mendus AB (publ) EPS is -2.2 SEK over the trailing 12 months.
Which sector does the Mendus AB (publ) company belong to?
The Mendus AB (publ) sector is Healthcare.
Mendus AB (publ) IMMU.ST included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| OMX Stockholm Health Care GI SX20GI | 4545.66 SEK 443.71 USD |
-0.71
|
— — | 4545.66 SEK 443.71 USD | 4608.67 SEK 449.86 USD | — - | — — |
| OMX Stockholm Pharmaceuticals a SX201030GI | 7742.42 SEK 755.76 USD |
+0.07
|
— — | 7742.42 SEK 755.76 USD | 7742.42 SEK 755.76 USD | — - | — — |
| OMX_Stockholm_Small_Cap_GI OMXSSCGI | 648.16 SEK 63.27 USD |
-1.15
|
— — | 647.79 SEK 63.23 USD | 659.11 SEK 64.34 USD | — - | — — |
| OMX Stockholm_GI OMXSGI | 481.26 SEK 46.98 USD |
-0.36
|
— — | 480.04 SEK 46.86 USD | 486.31 SEK 47.47 USD | — - | — — |
| OMX_Nordic_Small_Cap_SEK_GI OMXNSCSEKGI | 450.91 SEK 44.01 USD |
-0.49
|
— — | 450.83 SEK 44.01 USD | 454.95 SEK 44.41 USD | — - | — — |
| OMX_Nordic_Small_Cap_EUR_GI OMXNSCEURGI | 371.51 EUR 406.12 USD |
-0.61
|
— — | 371.38 EUR 405.97 USD | 375.64 EUR 410.63 USD | — - | — — |
| OMX Affarsvarldens Generalindex OMXAFGX | 943.97 SEK 92.14 USD |
-0.39
|
— — | 941.76 SEK 91.93 USD | 954.17 SEK 93.14 USD | — - | — — |
| NASDAQ OMX Small Cap Sweden GI NOMXSCSEGI | 4355.05 SEK 425.11 USD |
-0.64
|
— — | 4345.93 SEK 424.22 USD | 4403.71 SEK 429.86 USD | — - | — — |
| OMX Stockholm Health Care PI SX20PI | 3528.12 SEK 344.39 USD |
-0.99
|
— — | 3522.7 SEK 343.86 USD | 3558.23 SEK 347.33 USD | — - | — — |
| OMX Stockholm Pharmaceuticals a SX201030PI | 5704.1 SEK 556.79 USD |
0
|
— — | 5704.1 SEK 556.79 USD | 5704.1 SEK 556.79 USD | — - | — — |
| OMX_Stockholm_Small_Cap_PI OMXSSCPI | 1284.82 SEK 125.41 USD |
-1.15
|
— — | 1284.1 SEK 125.34 USD | 1306.53 SEK 127.53 USD | — - | — — |
| OMX Stockholm_PI OMXSPI | 967.74 SEK 94.46 USD |
-0.4
|
— — | 965.71 SEK 94.27 USD | 978.33 SEK 95.5 USD | — - | — — |
| OMX Stockholm All-Share Cap_GI OMXSCAPGI | 471.3 SEK 46 USD |
-0.37
|
— — | 470.18 SEK 45.9 USD | 476.32 SEK 46.49 USD | — - | — — |
| OMX_Nordic_Small_Cap_ISK_GI OMXNSCISKGI | 547.76 ISK 4.03 USD |
-0.47
|
— — | 547.51 ISK 4.03 USD | 553.81 ISK 4.07 USD | — - | — — |
| OMX_Nordic_Small_Cap_DKK_GI OMXNSCDKKGI | 371.67 DKK 54.49 USD |
-0.61
|
— — | 371.52 DKK 54.47 USD | 375.78 DKK 55.1 USD | — - | — — |
| NASDAQ OMX Small Cap Sweden PI NOMXSCSEPI | 2697.02 SEK 263.26 USD |
-0.64
|
— — | 2691.37 SEK 262.71 USD | 2727.15 SEK 266.2 USD | — - | — — |
| OMX Stockholm Health Care PI SX4000PI | 2712.52 SEK 264.78 USD |
<0.01
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}